DelveInsight's 'Dry Age-Related Macular Degeneration Pipeline Insight 2025' report provides comprehensive global coverage of ...
AMD progresses through several stages, usually starting with dry AMD, which is the more common form of the condition. It advances to geographic atrophy (GA) in some cases. Both conditions damage ...
The charity has described the UK medicine regulator’s decision not to approve Syfovre as “undoubtedly disappointing news” ...
Approximately a quarter of Medicare Advantage prescription drug plan members with geographic atrophy also have wet AMD.
Breakthroughs in age-related macular degeneration (AMD) treatments have revolutionized the management of this progressive and potentially devastating eye disease. These include treatments such as ...
The trial found that LumiThera’s Valeda Light Delivery System significantly reduced the risk of vision loss and the start of geographic atrophy in dry AMD. More than 58% of the people studied ...
Regenxbio's rolling BLA submission completion of RGX-121 for the treatment of patients with MPS II expected in Q1 of 2025.
Medication is sometimes necessary to treat eye conditions and vision problems. Of course, this is highly dependent on the ...
PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, today announces it has submitted a ...